MPA-AUC thresholds in kidney and liver transplant recipients maintained on mycophenolate or EC-MPS with and without pantoprazole
| MPA-AUC12 h thresholds, mg*h/L . | MMF (n = 19) . | MMF + pantoprazole (n = 19) . | EC-MPS (n = 21) . | EC-MPS + pantoprazole (n = 21) . |
|---|---|---|---|---|
| >30 | 17 (89.5) | 13 (68.4) | 16 (76.2) | 17 (81.0) |
| >40 | 15 (78.9) | 10 (52.6) | 10 (47.6) | 14 (66.7) |
| >50 | 11 (57.9) | 8 (42.1) | 5 (23.8) | 10 (47.6) |
| >60 | 10 (52.6) | 7 (36.8) | 4 (19.0) | 9 (42.9) |
| MPA-AUC12 h thresholds, mg*h/L . | MMF (n = 19) . | MMF + pantoprazole (n = 19) . | EC-MPS (n = 21) . | EC-MPS + pantoprazole (n = 21) . |
|---|---|---|---|---|
| >30 | 17 (89.5) | 13 (68.4) | 16 (76.2) | 17 (81.0) |
| >40 | 15 (78.9) | 10 (52.6) | 10 (47.6) | 14 (66.7) |
| >50 | 11 (57.9) | 8 (42.1) | 5 (23.8) | 10 (47.6) |
| >60 | 10 (52.6) | 7 (36.8) | 4 (19.0) | 9 (42.9) |
Data are expressed as n (%).
MPA-AUC thresholds in kidney and liver transplant recipients maintained on mycophenolate or EC-MPS with and without pantoprazole
| MPA-AUC12 h thresholds, mg*h/L . | MMF (n = 19) . | MMF + pantoprazole (n = 19) . | EC-MPS (n = 21) . | EC-MPS + pantoprazole (n = 21) . |
|---|---|---|---|---|
| >30 | 17 (89.5) | 13 (68.4) | 16 (76.2) | 17 (81.0) |
| >40 | 15 (78.9) | 10 (52.6) | 10 (47.6) | 14 (66.7) |
| >50 | 11 (57.9) | 8 (42.1) | 5 (23.8) | 10 (47.6) |
| >60 | 10 (52.6) | 7 (36.8) | 4 (19.0) | 9 (42.9) |
| MPA-AUC12 h thresholds, mg*h/L . | MMF (n = 19) . | MMF + pantoprazole (n = 19) . | EC-MPS (n = 21) . | EC-MPS + pantoprazole (n = 21) . |
|---|---|---|---|---|
| >30 | 17 (89.5) | 13 (68.4) | 16 (76.2) | 17 (81.0) |
| >40 | 15 (78.9) | 10 (52.6) | 10 (47.6) | 14 (66.7) |
| >50 | 11 (57.9) | 8 (42.1) | 5 (23.8) | 10 (47.6) |
| >60 | 10 (52.6) | 7 (36.8) | 4 (19.0) | 9 (42.9) |
Data are expressed as n (%).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
